Women's health · Lining changes · Evidence stated plainly

Vaginal atrophy treatment: options, limits and evidence

Different options act on different problems.

Thinning of the vaginal lining can be treated in more than one way. This guide puts non-device options first, and it is open about the limits of laser.

Exam
Before Any Plan
Doctor
Examines You First
Written
Quote After Exam
Orchard
By Appointment

In Brief

Vaginal atrophy treatment aims to ease symptoms from thinning of the vaginal lining around menopause. Moisturisers, lubricants and prescribed oestrogen are standard options. Laser is considered for some women after examination, but the evidence is mixed. It cannot strengthen muscles or correct prolapse. Results vary.

About This Treatment

What vaginal atrophy means

Vaginal atrophy means thinning of the vaginal lining. Lubrication can fall at the same time. Women may notice irritation, itching, dryness and discomfort during sex. Research papers also use the terms vulvovaginal atrophy and genitourinary syndrome of menopause.

The lining is one issue. Muscle weakness, stretched tissue and prolapse are others, and each needs a different answer. A treatment for the lining will not fix a problem elsewhere. That is why an examination matters before you choose. It also means that a woman can have more than one cause, and that one option alone may not cover them. Results vary.

Vaginal atrophy treatment options at a glance

OptionWhat it doesWhat it cannot do
Moisturisers and lubricantsImprove surface comfort and reduce frictionChange lining thickness or laxity
Prescribed vaginal oestrogenSupports the lining where low oestrogen drives thinningTreat looseness from stretched tissue
Pelvic floor exercisesStrengthen muscles that support the bladder, vagina and bowelChange the quality of the lining
Fractional CO2 laser (G Lift)Delivers heat to the lining to stimulate collagenStrengthen the pelvic floor or correct prolapse
Surgical repairTightens the canal or repairs support tissues, by referralServe as a non-surgical option

Start without a device

Moisturisers, lubricants and prescribed vaginal oestrogen remain standard options for dryness. Moisturisers and lubricants act on surface comfort, so they suit mild dryness and discomfort during sex. Prescribed oestrogen acts on the lining where low oestrogen is the driver. It needs a doctor's assessment and a prescription. If you have had cancer treatment, discuss it with your oncologist where relevant. For more on the first steps, read our guide to vaginal dryness after menopause.

What regulators and societies have said

FDA, 2018

The US Food and Drug Administration warned about energy-based devices marketed for vaginal rejuvenation. It said it had not evaluated these devices for those uses. It reported vaginal burns, scarring, painful intercourse and chronic pain, and sent notices to seven manufacturers.

ISSVD and ICS, 2018

The International Society for the Study of Vulvovaginal Disease and the International Continence Society recommended against using laser and radiofrequency for vulvovaginal atrophy. They said the devices should not be used for lichen sclerosus, vulvodynia, urinary incontinence or rejuvenation outside properly designed clinical trials.

ACOG, 2021

The American College of Obstetricians and Gynecologists stated that laser is neither FDA-approved nor FDA-cleared for symptoms related to menopause. It called the evidence mostly small observational studies and said more research is needed before recommending it.

What the trials show

Two papers help frame the question. In a JAMA trial of 85 women, fractional CO2 laser did not significantly improve vaginal symptoms after 12 months compared with sham. A 2022 review of six randomised trials with 270 women found that CO2 laser was associated with similar improvement in genitourinary symptoms as vaginal oestrogen, with no significant differences on the main measures. So the picture is not simple. Most published studies are small, and sham-controlled trials have given mixed results. Neither paper tells you how you will respond. Our evidence library lists published sources.

How laser is used, if it is used

If you and your doctor decide to discuss a device, our G Lift is the relevant option for the lining. It is a fractional CO2 laser at 10,600 nm, the MonaLisa Touch, used through a vaginal probe. Treatment takes minutes, as an outpatient, without anaesthesia. It is usually felt as a light vibration. Some women may use it alongside or instead of vaginal oestrogen, which is a choice to make with a doctor. The course and any maintenance are planned individually, so no standard number of sessions is quoted.

Who should wait, avoid it or be referred

Wait

Pregnancy, breastfeeding until suitability is discussed, active infection including a herpes outbreak, undiagnosed bleeding, or an unresolved abnormal cervical screen.

Assess individually

Pelvic mesh or implants, and recent pelvic surgery or radiotherapy.

Refer

Prolapse or structural problems go to a gynaecologist or urogynaecologist. Leaking of unclear cause goes for urinary or pelvic floor assessment.

Risks and warning signs

Mild discharge, spotting, irritation or tenderness can follow laser. Infection, burn, scarring and discomfort during intercourse are uncommon. Your symptoms may not change at all. Aftercare covers tampons, vaginal products, douching, swimming, hot baths, saunas and strenuous exercise. Intercourse waits until you are advised at review. Contact the clinic the same day for heavy bleeding, bleeding that does not settle, fever, foul discharge, increasing pelvic pain, worsening burning on passing urine, severe pain, new leaking, or a feeling of bulging.

What to ask before you decide

01
What is causing my symptoms?
Ask whether the lining, the muscles or support tissues are involved.
02
What can I try without a device?
Ask about moisturisers, lubricants and prescribed oestrogen first.
03
What are the risks for me?
Ask how your history, including any cancer treatment, changes the advice.
04
What if I do nothing?
No treatment is a valid choice. Our consultation guide explains how a visit runs.

Frequently Asked Questions

Moisturisers and lubricants for surface comfort, and a talk with a doctor about prescribed vaginal oestrogen. A device is not the first step.
The evidence is mixed. One 85-woman trial found no significant benefit over sham at 12 months, while a six-trial review found similar improvement to vaginal oestrogen.
ACOG stated that laser is neither FDA-approved nor FDA-cleared for symptoms related to menopause, and the FDA issued its caution about vaginal rejuvenation in 2018.
It is not a substitute for assessment. Leaking has several causes, and pelvic floor physiotherapy remains a first step.
No. Moisturisers improve surface comfort and reduce friction, but they do not change lining thickness.
Discuss this with your doctor before changing anything. For some women laser may be used alongside or instead of it.
No. Pregnancy, active infection, undiagnosed bleeding and prolapse needing assessment are among the reasons to wait or be referred.
SY
Dr Sin Yong
MBBS (NUS) · MRCS (Edinburgh)
MSc Aesthetic Medicine (QMUL) · MSc Practical Dermatology (Cardiff)
Aesthetic physician registered with the Singapore Medical Council.

Find out what is causing your symptoms

Dr Sin Yong will examine you, explain your options and give any fee in writing.

WhatsApp the Clinic

References

  1. Li FG, et al. Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial. JAMA. 2021;326(14):1381-1389. View source
  2. US Food and Drug Administration. Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to safeguard women's health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for "vaginal rejuvenation". FDA statement. 2018. View source
  3. Jang YC, et al. Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(9):e2232563. View source
  4. International Society for the Study of Vulvovaginal Disease, International Continence Society. ISSVD/ICS comments on the FDA communication on the use of energy-based devices to perform vaginal 'rejuvenation' or vaginal cosmetic procedures. ISSVD/ICS position statement. 2018. View source
  5. American College of Obstetricians and Gynecologists. Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer: Clinical Consensus. ACOG Clinical Consensus No. 2. 2021. View source

Studies may involve other devices or protocols, and they do not predict your own result. See our evidence library and editorial policy.

Related Treatments

Last updated 3 November 2026. General information only. Results vary between individuals. Images are illustrative and do not show patients.